Biologic imaging of head and neck cancer: The present and the future

American Journal of Neuroradiology

Volumn 33, Issue 4, 2012, Pages 586-594

  Srinivasan, Ashok ^a   Mohan, S ^a   Mukherji, S K ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE TRIPHOSPHATE; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18;

CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; HEAD AND NECK CANCER; HUMAN; HYPOXIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TREATMENT RESPONSE; TUMOR VOLUME;

HEAD AND NECK NEOPLASMS; HUMANS; MOLECULAR IMAGING; NEOVASCULARIZATION, PATHOLOGIC; NEUROIMAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 84860227398     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2535     Document Type: Review

References (67)

1. American Cancer Society. www.cancer.org. Accessed October 28, 2007
2. Delikatny EJ, Russell P, Hunter JC, et al. Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. Radiology 1993;188:791-96 (Pubitemid 23254603)
3. Gill SS, Thomas DG, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr 1990;14:497-504 (Pubitemid 20217153)
4. Negendank WG, Brown TR, Evelhoch JL, et al. Proceedings of a National Cancer Institute workshop: MR spectroscopy and tumor cell biology. Radiology 1992;185:875-83
5. Shah GV, Gandhi D, Mukherji SK. Magnetic resonance spectroscopy of head and neck neoplasms. Top Magn Reson Imaging 2004;15:87-94 (Pubitemid 38987407)
6. Vogl T, Peer F, Schedel H, et al. 31P-spectroscopy of head and neck tumors: surface coil technique. Magn Reson Imaging 1989;7:425-35 (Pubitemid 20021973)
7. Yeung DK, Fong KY, Chan QC, et al. Chemical shift imaging in the head and neck at 3T: initial results. J Magn Reson Imaging 2010;32:1248-54
8. Mukherji SK, Schiro S, Castillo M, et al. ProtonMRspectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol 1997;18:1057-72 (Pubitemid 30412127)
9. Mukherji SK, Schiro S, Castillo M, et al. ProtonMRspectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. AJNR Am J Neuroradiol 1996;17:1485-90 (Pubitemid 26336813)
10. King AD, Yeung DK, Ahuja AT, et al. In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma. AJNR Am J Neuroradiol 2004;25:484-90 (Pubitemid 38374933)
11. King AD, Yeung DK, Ahuja AT, et al. In vivo 1H MR spectroscopy of thyroid carcinoma. Eur J Radiol 2005;54:112-17
12. Maheshwari SR, Mukherji SK, Neelon B, et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. AJNR Am J Neuroradiol 2000;21:1930-35
13. Krouwer HG, Kim TA, Rand SD, et al. Single-voxel protonMRspectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. AJNR Am J Neuroradiol 1998;19:1695-703 (Pubitemid 30413761)
14. Rand SD, Prost R, Haughton V, et al. Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions. AJNR Am J Neuroradiol 1997;18:1695-704 (Pubitemid 30399769)
15. King AD, Yeung DK, Ahuja AT, et al. Salivary gland tumors at in vivo proton MR spectroscopy. Radiology 2005;237:563-69 (Pubitemid 41507895)
16. King AD, Yeung DK, Yu KH, et al. Monitoring of treatment response after chemoradiotherapy for head and neck cancer using in vivo 1H MR spectroscopy. Eur Radiol 2010;20:165-72. Epub 2009 Aug 5
17. Bezabeh T, Odlum O, Nason R, et al. Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy. AJNR Am J Neuroradiol 2005;26:2108-13
18. King AD, Yeung DK, Yu KH, et al. Pretreatment and early intratreatment prediction of clinicopathologic response of head and neck cancer to chemoradiotherapy using 1H-MRS. J Magn Reson Imaging 2010;32:199-203
19. Lee TY. Functional CT: physiological models. Trends Biotechnol 2002;20:S3-10
20. Lee TY, Purdie TG, Stewart E. CT imaging of angiogenesis. Q J Nucl Med 2003;47:171-87 (Pubitemid 37279154)
21. Gandhi D, Hoeffner EG, Carlos RC, et al. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract: initial results. J Comput Assist Tomogr 2003;27:687-93 (Pubitemid 37087737)
22. Rumboldt Z, Al-Okaili R, Deveikis JP. Perfusion CT for head and neck tumors: pilot study. AJNR Am J Neuroradiol 2005;26:1178-85 (Pubitemid 43821970)
23. Bisdas S, Baghi M, Smolarz A, et al. Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies. Invest Radiol 2007;42:172-79 (Pubitemid 46232822)
24. Bisdas S, Rumboldt Z, Surlan-Popovic K, et al. Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements. AJNR Am J Neuroradiol 2010;31:576-81. Epub 2009 Oct 29
25. Bisdas S, Nguyen SA, Anand SK, et al. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys 2009;73:1313-18
26. Zima A, Carlos R, Gandhi D, et al. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol 2007;28:328-34 (Pubitemid 46281057)
27. Surlan-Popovic K, Bisdas S, Rumboldt Z, et al. Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. AJNR Am J Neuroradiol 2010;31:570-75. Epub 2009 Oct 29
28. Ash L, Teknos TN, Gandhi D, et al. Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density. Radiology 2009;251:422-28
29. Lacerda S, Law M. Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroimaging Clin N Am 2009;19:527-57
30. Ludemann L, Warmuth C, Plotkin M, et al. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography. Eur J Radiol 2009;70:465-74
31. Bisdas S, Baghi M, Wagenblast J, et al. Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysis. J Magn Reson Imaging 2008;27:963-69 (Pubitemid 351614605)
32. Cao Y, Popovtzer A, Li D, et al. Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. Int J Radiat Oncol Biol Phys 2008;72:1287-90
33. de Bondt RB, Hoeberigs MC, Nelemans PJ, et al. Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology 2009;51:183-92
34. Eida S, Sumi M, Sakihama N, et al. Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy. AJNR Am J Neuroradiol 2007;28:116-21 (Pubitemid 46147546)
35. Holzapfel K, Duetsch S, Fauser C, et al. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2009;72:381-87
36. Srinivasan A, Dvorak R, Perni K, et al. Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience. AJNR Am J Neuroradiol 2008;29:40-44
37. Srinivasan A, Dvorak R, Rohrer S, et al. Initial experience of 3-Tesla apparent diffusion coefficient values in characterizing squamous cell carcinomas of the head and neck. Acta Radiol 2008;49:1079-84
38. Vandecaveye V, De Keyzer F, Vander Poorten V, et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009;251:134-46
39. Habermann CR, Arndt C, Graessner J, et al. Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? AJNR Am J Neuroradiol 2009;30:591-96
40. Habermann CR, Gossrau P, Graessner J, et al. Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors? Rofo 2005;177:940-45 (Pubitemid 40977363)
41. Matsushima N, Maeda M, Takamura M, et al. Apparent diffusion coefficients of benign and malignant salivary gland tumors: comparison to histopathological findings. J Neuroradiol 2007;34:183-89 (Pubitemid 47042899)
42. Dirix P, De Keyzer F, Vandecaveye V, et al. Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy. Int J Radiat Oncol Biol Phys 2008;71:1365-71
43. Vandecaveye V, De Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 2007;67:960-71
44. Abdel Razek AA, Kandeel AY, Soliman N, et al. Role of diffusion-weighted echoplanar MR imaging in differentiation of residual or recurrent head and neck tumors and post-treatment changes. AJNR Am J Neuroradiol 2007;28:1146-52 (Pubitemid 46984559)
45. Vandecaveye V, de Keyzer F, Vander Poorten V, et al. Evaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases. Br J Radiol 2006;79:681-87 (Pubitemid 44283158)
46. Hamstra DA, Lee KC, Moffat BA, et al. Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. Transl Oncol 2008;1:187-94
47. Galban CJ, Mukherji SK, Chenevert TL, et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009;2:184-90
48. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009;15:986-94
49. Kato H, Kanematsu M, Tanaka O, et al. Head and neck squamous cell carcinoma: usefulness of diffusion-weightedMRimaging in the prediction of a neoadjuvant therapeutic effect. Eur Radiol 2009;19:103-09
50. Vandecaveye V, Dirix P, De Keyzer F, et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010;20:1703-14
51. Fukui MB, Blodgett TM, Snyderman CH, et al. Combined PET-CT in the head and neck. Part 2. Diagnostic uses and pitfalls of oncologic imaging. Radiographics 2005;25:913-30 (Pubitemid 41196929)
52. Wong RJ, Lin DT, Schoder H, et al. Diagnostic and prognostic value of [F-18]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199-208 (Pubitemid 35191022)
53. Al-Ibraheem A, Buck A, Krause BJ, et al. Clinical applications of FDG PET and PET/CT in head and neck cancer. J Oncol 2009;2009:208725. Epub 2009 Aug 20
54. Ong SC, Schoder H, Lee NY, et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008;49:532-40 (Pubitemid 351520600)
55. Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 2008;33:210-22 (Pubitemid 351799005)
56. Kao J, Vu HL, Genden EM, et al. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer 2009;115:4586-94
57. Subramaniam RM, Truong M, Peller P, et al. Fluorodeoxyglucose-positron- emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol 2010;31:598-604. Epub 2009 Nov 12
58. Troost EG, Schinagl DA, Bussink J, et al. Innovations in radiotherapy planning of head and neck cancers: role of PET. J Nucl Med 2010;51:66-76. Epub 2009 Dec 15
59. Akter M, Hirai T, Minoda R, et al. Diffusion tensor tractography in the head-and-neck region using a clinical 3-TMRscanner. Acad Radiol 2009;16:858-65
60. Schoder H, Fury M, Lee N, Kraus D. PET monitoring of therapy response in head and neck squamous cell carcinoma. J NuclMed2009;50(suppl 1):74S- 88S
61. Eschmann SM, Paulsen F, Reimold M, et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 2005;46:253-60 (Pubitemid 43073432)
62. Rischin D, Hicks RJ, Fisher R, et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006;24:2098-104 (Pubitemid 46622121)
63. KimJJ, Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 2005;5:516-25 (Pubitemid 40942828)
64. Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 1998;4:1334-36 (Pubitemid 28512118)
65. Cobben DC, van der Laan BF, Maas B, et al. 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET. J Nucl Med 2004;45:226-31 (Pubitemid 47618641)
66. Linecker A, Kermer C, Sulzbacher I, et al. Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival. Nuklearmedizin 2008;47:80-85, quiz N12
67. Czernin J, Benz MR, Allen-Auerbach MS. PET/CT imaging: the incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination. Eur J Radiol 2010;73:470-80. Epub 2010 Jan 25